Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine transporter | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0162 | 0.1255 | 0.1727 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0162 | 0.1255 | 0.1216 |
Brugia malayi | Matrixin family protein | 0.0126 | 0.0863 | 0.0822 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0087 | 0.0432 | 0.0594 |
Schistosoma mansoni | integrin alpha-ps | 0.0141 | 0.1025 | 0.1608 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0064 | 0.017 | 0.5 |
Onchocerca volvulus | 0.0182 | 0.1484 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0333 | 0.3149 | 0.3119 |
Onchocerca volvulus | Matrilysin homolog | 0.0116 | 0.0748 | 0.4887 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.008 | 0.0347 | 0.0478 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0064 | 0.017 | 0.0126 |
Echinococcus multilocularis | integrin alpha ps | 0.0271 | 0.2459 | 0.3383 |
Loa Loa (eye worm) | matrixin family protein | 0.0126 | 0.0863 | 0.0822 |
Loa Loa (eye worm) | serotonin transporter b | 0.0182 | 0.1484 | 0.1446 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0116 | 0.0748 | 0.4887 |
Brugia malayi | Kelch motif family protein | 0.0145 | 0.1068 | 0.1028 |
Onchocerca volvulus | 0.0094 | 0.0501 | 0.3174 | |
Schistosoma mansoni | integrin alpha | 0.0604 | 0.6142 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0116 | 0.0748 | 0.0706 |
Loa Loa (eye worm) | integrin beta-2 | 0.0953 | 1 | 1 |
Echinococcus granulosus | integrin alpha ps | 0.0271 | 0.2459 | 0.3383 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0096 | 0.0531 | 0.073 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.0286 | 0.0396 |
Loa Loa (eye worm) | hypothetical protein | 0.0474 | 0.4707 | 0.4684 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0064 | 0.017 | 0.5 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0145 | 0.1068 | 0.1028 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0162 | 0.1255 | 0.1216 |
Mycobacterium ulcerans | hydrolase | 0.0064 | 0.017 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0182 | 0.1484 | 0.1446 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0182 | 0.1484 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.1484 | 0.1446 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0096 | 0.0531 | 0.073 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.017 | 0.0126 |
Schistosoma mansoni | alpha-glucosidase | 0.0139 | 0.1006 | 0.1577 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0128 | 0.088 | 0.137 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.1068 | 0.1028 |
Echinococcus granulosus | integrin alpha 3 | 0.0463 | 0.4584 | 0.6305 |
Schistosoma mansoni | hypothetical protein | 0.013 | 0.0901 | 0.1405 |
Echinococcus multilocularis | integrin alpha ps | 0.0271 | 0.2459 | 0.3383 |
Echinococcus multilocularis | integrin alpha ps | 0.013 | 0.0901 | 0.124 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0087 | 0.0432 | 0.0594 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0457 | 0.4516 | 0.4491 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.019 | 0.1567 | 0.2155 |
Echinococcus granulosus | integrin beta 2 | 0.0706 | 0.727 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0182 | 0.1484 | 0.1446 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.1484 | 0.1446 |
Echinococcus granulosus | glutamate receptor NMDA | 0.008 | 0.0347 | 0.0478 |
Brugia malayi | Hemopexin family protein | 0.0074 | 0.0286 | 0.0242 |
Schistosoma mansoni | integrin beta subunit | 0.0561 | 0.5669 | 0.9226 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0182 | 0.1484 | 0.236 |
Loa Loa (eye worm) | hypothetical protein | 0.0141 | 0.1025 | 0.0985 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0095 | 0.0513 | 0.0705 |
Echinococcus multilocularis | integrin alpha 3 | 0.0463 | 0.4584 | 0.6305 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0182 | 0.1484 | 0.236 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0096 | 0.0531 | 0.0798 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.019 | 0.1567 | 0.2155 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.1484 | 0.1446 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0162 | 0.1255 | 0.1727 |
Echinococcus multilocularis | integrin beta 2 | 0.0706 | 0.727 | 1 |
Onchocerca volvulus | 0.0074 | 0.0286 | 0.1677 | |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0182 | 0.1484 | 0.1446 |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 0.0901 | 0.0861 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0124 | 0.0839 | 0.1302 |
Schistosoma mansoni | integrin alpha-ps | 0.0271 | 0.2459 | 0.3961 |
Schistosoma mansoni | alpha-glucosidase | 0.0139 | 0.1006 | 0.1577 |
Echinococcus granulosus | integrin alpha ps | 0.013 | 0.0901 | 0.124 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0162 | 0.1255 | 0.1727 |
Echinococcus multilocularis | serotonin transporter | 0.0182 | 0.1484 | 0.2041 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0604 | 0.6142 | 0.6124 |
Brugia malayi | hypothetical protein | 0.0145 | 0.1068 | 0.1028 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0095 | 0.0513 | 0.0705 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0931 | 0.9756 | 0.9755 |
Loa Loa (eye worm) | hypothetical protein | 0.0457 | 0.4516 | 0.4491 |
Echinococcus granulosus | serotonin transporter | 0.0182 | 0.1484 | 0.2041 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7.8 nM | Binding affinity at the dopamine transporter using [125I]-RTI-55 in rat caudate membranes. | ChEMBL. | 9057857 |
IC50 (binding) | = 7.8 nM | Binding affinity at the dopamine transporter using [125I]-RTI-55 in rat caudate membranes. | ChEMBL. | 9057857 |
IC50 (functional) | = 25 nM | Reuptake inhibition at the dopamine transporter labeled with radioligand [3H]-dopamine on synaptosomes obtained from rat caudate. | ChEMBL. | 9057857 |
IC50 (functional) | = 25 nM | Reuptake inhibition at the dopamine transporter labeled with radioligand [3H]-dopamine on synaptosomes obtained from rat caudate. | ChEMBL. | 9057857 |
IC50 (binding) | = 46 nM | Binding affinity at the serotonin transporter using [125I]-RTI-55 in rat caudate membranes. | ChEMBL. | 9057857 |
IC50 (binding) | = 46 nM | Binding affinity at the serotonin transporter using [125I]-RTI-55 in rat caudate membranes. | ChEMBL. | 9057857 |
IC50 (functional) | = 119 nM | Reuptake inhibition at the dopamine transporter labeled with radioligand [3H]-5-HT on synaptosomes obtained from whole rat brain minus cerebellum. | ChEMBL. | 9057857 |
IC50 (functional) | = 119 nM | Reuptake inhibition at the dopamine transporter labeled with radioligand [3H]-5-HT on synaptosomes obtained from whole rat brain minus cerebellum. | ChEMBL. | 9057857 |
Ratio (functional) | = 3.2 | Ratio of reuptake inhibition on DA with respect to binding affinity of DA | ChEMBL. | 9057857 |
Ratio (functional) | = 3.2 | Ratio of reuptake inhibition on DA with respect to binding affinity of DA | ChEMBL. | 9057857 |
Ratio (functional) | = 5 | Ratio of reuptake inhibition of 5-HT with respect to DA | ChEMBL. | 9057857 |
Ratio (binding) | = 6 | Ratio of binding affinity on SERT with respect to DA | ChEMBL. | 9057857 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.